GlaxoSmithkline Consumer Healthcare (Delisted) share news and announcements

BSE: 500676

Formerly Smithkline Beecham Consumer Healthcare

Last traded ₹10,732.60 on 15 Apr 2020

Delisted on 24 Jun 2021.

GlaxoSmithkline Consumer Healthcare share news and announcements

668 announcements, routine notices left out, newest first. Page 6 of 14.

Jul 2017
- 10 Jul · Meeting
  This is to inform you that pursuant to the provisions of Section 91 of the Companies Act, 2013, the Register of Members and the Share Transfer Books of the Company will remain closed from .... (opens in a new tab)
- 10 Jul · Board Meeting On, August 8, 2017
  Notice is hereby given that a meeting of the Board of Directors of the Company will .... (opens in a new tab)
- 10 Jul · Board meeting
  To, inter-alia, consider and take on record the unaudited Financial Results for the quarter ended June 30, 2017 with Limited Review by Auditors. (opens in a new tab)
May 2017
Apr 2017
- 17 Apr · Certificate In Terms Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015
  Please find enclosed the Certificate issued by Registrar and Share Transfer Agents certifying that the requirements under Regulation 7 (2) are complied with for the half year ended March .... (opens in a new tab)
- 17 Apr · Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Statement of number of Investor Complaints received and disposed of during the quarter ended March 31, 2017 under Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 11 Apr · Disclosure
  Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 7 Apr · Shareholding for the Period Ended March 31, 2017
  Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
Mar 2017
Feb 2017
Jan 2017
- 31 Jan · Results
  Meeting of the Board of Directors of the Company will be held on February 13, 2017, inter alia, to consider and take on record .... (opens in a new tab)
- 31 Jan · Board meeting
  To, inter alia, consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2016 with Limited Review by Statutory Auditors. (opens in a new tab)
- 11 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under .... (opens in a new tab)
- 9 Jan · Shareholding for the Period Ended December 31, 2016
  Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Nov 2016
Oct 2016
- 24 Oct · Results
  Meeting of the Board of Directors of the Company will be held on November 07, 2016, inter alia, to consider and take on record .... (opens in a new tab)
- 24 Oct · Board meeting
  To, inter alia, consider and take on record the Unaudited Financial Results for the quarter ended September 30, 2016 with Limited Review by Statutory Auditors. (opens in a new tab)
- 15 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, .... (opens in a new tab)
- 14 Oct · Shareholding for the Period Ended September 30, 2016
  Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
Aug 2016